Talzenna® (talazoparib)
for Prostate Cancer

Talzenna (talazoparib) is a PARP inhibitor used to treat certain types of breast and prostate cancer. It is prescribed for adults with HER2-negative, BRCA-mutated locally advanced or metastatic breast cancer. Talzenna is also used with enzalutamide to treat HRR gene-mutated metastatic castration-resistant prostate cancer. It works by slowing or stopping cancer cell growth.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Prostate Cancer